Aktuell May 10, 2024 BioVersys erweitert Serie-C-Runde auf 44,9 Millionen Franken BioVersys verstärkt die Zusammenarbeit mit GSK, um die Entwicklung von Alpibectir zur Behandlung von Tuberkulose zu beschleunigen. GSK beteiligt ...
News May 10, 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News Apr 30, 2024 Johnson & Johnson opens Innovation Hub in Allschwil Johnson & Johnson has opened its first J&J Innovation Hub on the European mainland at the Switzerland Innovation Park Basel Area. This represents...
Aktuell Mar 26, 2024 Zürcher Forschende machen Krebstherapie wieder wirksam Forschende der Universität Zürich und des Universitätsspitals Zürich haben herausgefunden, wie mutierte Blutkrebszellen wieder auf eine Immunther...
News Nov 03, 2023 EPFL and Novochizol to collaborate on designing more efficient immunotherapies A groundbreaking collaboration between EPFL's Laboratory of Biomaterials for Immunoengineering and Novochizol aims to revolutionize cancer treatm...
News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News Oct 18, 2023 Cimeio collaborating with the University of Pennsylvania The Basel-based start-up Cimeio has been offered an exceptional opportunity for a preclinical research collaboration with the University of Penns...
Factsheet Apr 10, 2024 Erfahren Sie mehr über den Markt für verarbeitete Lebensmittel in Indonesien Der indonesische Markt für ausländische verarbeitete Lebensmittel wird 2024 geschätzte 19,4 Mrd. US-Dollar erreichen. Das Land bietet zunehmende ...
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan Apr 23, 2024 10:15–12:10 Zürich Switzerland
Aktuell Jun 22, 2023 MSD weiht neues Forschungslabor in Schachen ein MSD Merck Sharp & Dohme (MSD) hat am Standort Schachen ein neues Forschungslabor eingeweiht. Dafür hat MSD 20 Millionen Franken investiert. Künft...
Actualités Nov 03, 2023 L’EPFL et Novochizol collaborent à la conception d’immunothérapies plus efficaces Une collaboration entre le Laboratoire de Biomatériaux pour l’Immuno-ingénierie de l’EPFL et Novochizol vise à révolutionner le traitement du can...
Fiches d’information Apr 10, 2024 Opportunités dans l’importation d’aliments transformés en Indonésie Le marché des aliments transformés importés en Indonésie pèse environ 19,4 milliards USD. Le pays offre des opportunités commerciales croissantes...
Actualités Apr 17, 2024 Addex Therapeutics lance la spin-off Neurosterix à Genève avec un investissement de USD 63 millions La société genevoise Addex Therapeutics s’est associée à Perceptive Advisors pour lancer la spin-off Neurosterix, un nouvel acteur dans le dévelo...
News Jan 29, 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
News Apr 23, 2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
News Jun 22, 2023 MSD opens new research laboratory in Schachen MSD Merck Sharp & Dohme (MSD) has opened a new research laboratory at its site in Schachen in the canton of Lucerne. MSD has invested 20 million ...
News Mar 26, 2024 Zurich researchers make cancer therapy effective again Researchers from the University of Zurich and University Hospital Zurich have discovered how mutated blood cancer cells can be made to respond to...
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon Apr 23, 2024 10:15–12:10 Zürich Switzerland